Back
Berkshire Hathaway Vs. Summit Therapeutics Industry Stock Comparison
Sell
40
BRK.A
Berkshire Hathaway
Last Price:
680,530.01
Seasonality Move:
5.54%
Sell
44
SMMT
Summit Therapeutics
Last Price:
19.72
Seasonality Move:
33.87%
Sell
40
Berkshire Hathaway (BRK.A)
is a Sell
Is Berkshire Hathaway a Buy, Sell or Hold?
- The current Berkshire Hathaway [BRK.A] share price is $680,000.10. The Score for BRK.A is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- BRK.A is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $18.92. The Score for SMMT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRK.A Stock Price Chart
What is Berkshire Hathaway's stock price today?
-
The Berkshire Hathaway share price today is $680,000.10
The current trend is moderately bearish and BRK.A is experiencing selling pressure, which indicates risk of future bearish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $18.92
The current trend is relatively stagnant and SMMT is experiencing slight selling pressure.
BRK.A Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1787.72 | Buy |
| Relative Strength Index (14 RSI): | 48.06 | Sell |
| Chaikin Money Flow: | -1817 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (687073.8 - 687093.8) | Sell |
| Bollinger Bands (100): | (650819.98 - 650879.98) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 47.31 | Sell |
| Chaikin Money Flow: | -209908 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.25 - 26.29) | Sell |
| Bollinger Bands (100): | (5.69 - 18.35) | Buy |
BRK.A Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 685397.69 | Sell |
| 20-day SMA: | 683534.02 | Sell |
| 50-day SMA: | 675466.91 | Buy |
| 200-day SMA: | 623905.73 | Buy |
| 8-day EMA: | 684775.62 | Sell |
| 20-day EMA: | 684361.23 | Sell |
| 50-day EMA: | 674570.66 | Buy |
| 200-day EMA: | 626635.19 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.23 | Sell |
| 20-day SMA: | 23.16 | Sell |
| 50-day SMA: | 16.44 | Buy |
| 200-day SMA: | 7.96 | Buy |
| 8-day EMA: | 20.12 | Sell |
| 20-day EMA: | 20.48 | Sell |
| 50-day EMA: | 17.38 | Buy |
| 200-day EMA: | 9.8 | Buy |
Berkshire Hathaway Earnings Growth & BRK.A Earnings Dates
- Analysts estimate an earnings increase this quarter of $290.50 per share, a decrease next quarter of $0.00 per share, an increase this year of $7,728.61 per share, and a decrease next year of $1,280.29 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and a decrease next year of $0.03 per share.
Berkshire Hathaway Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||